New therapeutics for traumatic brain injury : prevention of secondary brain damage and enhancement of repair and regeneration /

"New Therapeutics for Traumatic Brain Injury: Prevention of Secondary Brain Damage and Enhancement of Repair and Regeneration explores traumatic brain injury (TBI), a major cause of death and disability throughout the world. The delayed nature of the secondary injury phase suggests that there i...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Heidenreich, Kim A. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Academic Press is an imprint of Elsevier, [2017]
Temas:
Brain damage > Treatment.
Brain damage > Rehabilitation.
Brain > Wounds and injuries > Complications.
Brain Injuries, Traumatic > drug therapy
Brain Injuries, Traumatic > complications
Brain > drug effects
Clinical Trials as Topic
Cerveau > L�esions et blessures > Traitement.
Cerveau > L�esions et blessures > Complications et s�equelles.
MEDICAL > Neurology.
Internet Resources.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Part I: Interventional therapies for TBI previously or currently in phase 3 clinical trials. Why did the phase III clinical trials for progesterone in TBI fail? An analysis of three potentially critical factors / D.G. Stein, R.B. Howard, I. Sayeed
  • Hypothermia for traumatic brain injury: current evidence and future directions / H. Mtaweh, D. Simon, M.J. Bell
  • The future of TBI: hyperbaric oxygen as a primary therapeutic approach / B. Miskin, L.A. Fox
  • Part II: Repurposing FDA approved drugs for TBI treatment. Erythropoietin and its derivatives: mechanisms of neuroprotection and challenges in clinical translation / T. Bogoslovsky, J.D. Bernstock, K. Kenney, C. Moore, R. Diaz-Arrastia
  • Atorvastatin in the treatment of traumatic brain injury / A.N. Sen, S.P. Gopinath, C.S. Robertson
  • The application of glibenclamide in traumatic brain injury / D.S. Hersh, J.M. Simard, H.M. Eisenberg
  • Perispinal etanercept for traumatic brain injury / E. Tobinick, H. Rodriguez-Romanacce, R. Kinssies, N. Kim
  • Part III: Interventional drugs for TBI in phase 1-2 clinical trials. Nitric oxide synthase inhibitors in traumatic brain injury / R. Schinzel, F. Tegtmeier
  • Management of paroxysmal sympathetic hyperactivity after traumatic brain injury / L.D. Wilson, T.C. Leath, M.B. Patel
  • Part IV: Interventional drugs for TBI in preclinical development. The use of estrogen for the treatment of traumatic brain injury / W.J. Hubbard, I.H. Chaudry
  • Voltage-gated calcium channel blockers for the treatment of traumatic brain injury / G.G. Gurkoff, K. Shahlaie, B.G. Lyeth, R.F. Berman
  • 5-lipoxygenase-activating protein inhibitors: promising drugs for treating acute and chronic neuroinflammation following brain injury / K.A. Heidenreich, C.E. Corser-Jensen
  • Carbonyl scavenging as an antioxidant neuroprotective strategy for acute traumatic brain injury / J.E. Cebak, I.N. Singh, J.A. Wang, R.L. Hill, J.R. Kulbe, E.D. Hall
  • TrkB receptor agonist 7,8-Dihydroxyflavone and its therapeutic potential for traumatic brain injury / J. Romeika, M. Wurzelmann, D. Sun
  • Ceftriaxone treatment of TBI / M.Q. Hameed, A. Rotenberg
  • Part V: Drugs for TBI rehabilitation. Memantine: a safe and tolerable NMDA antagonist with potential benefits in traumatic brain injury / M.A. Keiski
  • Interventional drugs for TBI Rehabilitation of cognitive impairment: the cholinesterase inhibitor rivastigmine / M.A. Hernandez-Tejada, O. Brawman-Mintzer
  • Docosahexaenoic acid and omega 3 fatty acids / M.E. Schober
  • Treatment of mood disorders following traumatic brain injury / H.L. Lin, R.E. Jorge

Ejemplares similares